Literature DB >> 26600922

Higher Rate of Intracerebral Hemorrhage in Hispanic Patients with Cerebral Cavernous Malformation.

Amanda V Jenson1, Gustavo J Rodriguez1, Luis A Alvarado1, Salvador Cruz-Flores1, Alberto Maud1.   

Abstract

UNLABELLED: Cerebral cavernous malformations (CCM) are vascular malformations prone to intracerebral hemorrhage and epilepsy. Studies about the natural history and clinical presentation in the Hispanic population are lacking [7]. Retrospectively, we identified demographics and clinical features of Hispanic patients with CCM in our neurology clinic. Comparison with studies in the non-Hispanic White population with CCM was conducted.
RESULTS: A total of 15 Hispanic patients diagnosed with CCM were identified in our neurology clinic. The majority of our patients presented with symptomatic hemorrhage (27%, n = 4) or seizure(s) (47%, n = 7). Of 15 patients, there were a total of four patients (27%) that had recurrent hemorrhages with an annual rate of recurrent hemorrhage of 8.04%. Our cohort had a higher rate of intracerebral hemorrhage after any initial mode of presentation (47%, n = 7) compared with non-Hispanic White population studies: 11% (n = 32) and 4% (n = 5). (p < 0.05).
CONCLUSIONS: Hispanic patients with CCM have a higher rate of hemorrhage during follow-up after any presentation of CCM (p<0.05) when compared to CCM in the non-Hispanic White population.

Entities:  

Year:  2015        PMID: 26600922      PMCID: PMC4634773     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  14 in total

1.  Prospective hemorrhage risk of intracerebral cavernous malformations.

Authors:  K D Flemming; M J Link; T J H Christianson; R D Brown
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

2.  Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas.

Authors:  E Pozzati; N Acciarri; F Tognetti; F Marliani; F Giangaspero
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

3.  Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.

Authors:  Hélène Choquet; Jeffrey Nelson; Ludmila Pawlikowska; Charles E McCulloch; Amy Akers; Beth Baca; Yasir Khan; Blaine Hart; Leslie Morrison; Helen Kim
Journal:  Cerebrovasc Dis       Date:  2013-12-21       Impact factor: 2.762

4.  Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Salvador Cruz-Flores; Alejandro Rabinstein; Jose Biller; Mitchell S V Elkind; Patrick Griffith; Philip B Gorelick; George Howard; Enrique C Leira; Lewis B Morgenstern; Bruce Ovbiagele; Eric Peterson; Wayne Rosamond; Brian Trimble; Amy L Valderrama
Journal:  Stroke       Date:  2011-05-26       Impact factor: 7.914

5.  Risk factors for intracerebral and subarachnoid hemorrhage among Hispanics and non-Hispanic whites in a New Mexico community.

Authors:  A Bruno; C Qualls
Journal:  Neuroepidemiology       Date:  2000 Jul-Aug       Impact factor: 3.282

Review 6.  Cerebral cavernous malformations and epilepsy.

Authors:  Issam Awad; Pascal Jabbour
Journal:  Neurosurg Focus       Date:  2006-07-15       Impact factor: 4.047

Review 7.  Genetics of cavernous angiomas.

Authors:  Pierre Labauge; Christian Denier; Francoise Bergametti; Elisabeth Tournier-Lasserve
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

8.  Barriers to acute stroke therapy and stroke prevention in Mexican Americans.

Authors:  L B Morgenstern; L Steffen-Batey; M A Smith; L A Moyé
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

9.  Does socioeconomic status or acculturation modify the association between ethnicity and hypertension treatment before stroke?

Authors:  Deborah A Levine; Lewis B Morgenstern; Kenneth M Langa; Lesli E Skolarus; Melinda A Smith; Lynda D Lisabeth
Journal:  Stroke       Date:  2013-09-17       Impact factor: 7.914

10.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more
  2 in total

1.  Simvastatin improves intracerebral hemorrhage through NF-κB-mediated apoptosis via the MyD88/TRIF signaling pathway.

Authors:  Chengyao Gu; Yunqin Wu; Zhenyi Fan; Weiwei Han
Journal:  Exp Ther Med       Date:  2017-10-23       Impact factor: 2.447

2.  Anti-inflammatory effects of Simvastatin in patients with acute intracerebral hemorrhage in an intensive care unit.

Authors:  Xiurong Zhou; Jiafeng Chen; Chengdong Wang; Lili Wu
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.